Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors

Somatic mutations of isocitrate dehydrogenase 1 (IDH1R132) genes are found in 6–10% of AML [1]. IDH1R132 mutations are most frequent in cytogenetically normal AML and significantly associated with ...